参考文献/References:
[1] Wu N,Tong S,Xiang Y,et al.Association of hemostatic markers with atrial fibrillation: a meta analysis and meta-regression[J].PLoS One,2015,10(4):e0124716.
[2] Lim HS,Willoughby SR,Schultz C,et al.Effect of atrial fibrillation on atrial thrombogenesis in humans:impact of rate and rhythm[J].J Am Coll Cardiol,2013,61(8):852-860.
[3] Nobuyuki F,Tadakazu H,Kazumasa O,et al.Relation of the severity of mitral regurgitation to thromboembolic risk in patients with atrial fibrillation[J].Int J Cardiol,2011,146(2):197-201.
[4] Faucheier L,Philippart R,Clementy N,et al.How to define valvular atrial fibrillation?[J]. Arch Cardiovasc Dis,2015,S1875-2136(15):00116-3.
[5] Khoo CW,Krishnamoorthy S,Lim HS,et al.Atrial fibrillation, arrhythmia burden and thrombogenesis[J].Int J Cardiol,2012,157(3):318-323.
[6] Cresti A,García-Fernández MA,Miracapillo G,et al.Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter[J].J Am Soc Echocardiogr,2014,27(11):1200-1207.
[7] Jen N,Yu F,Lee J,et al.Atrial fibrillation pacing decreases intravascular shear stress in a New Zealand white rabbit model:implications in endothelial function[J].Biomech Model Mechanobiol,2013,12(4):735-745.
[8] Busch R,Strohbach A,Pennewitz M,et al.Regulation of the endothelial apelin/APJ system by hemodynamic fluid flow[J].Cell Signal,2015,27(7):1286-1296.
[9] Steinberg BA,Hellkamp AS,Lokhnygina Y,et al.Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation:results from the ROCKET-AF trial[J].Eur Heart J,2015,36(5):288-296.
[10] Brambatti M,Connolly SJ,Gold MR,et al.Temporal relationship between subclinical atrial fibrillation and embolic events[J]. Circulation,2014,129(21):2094-2099.
[11] Hirsh BJ,Copeland-Halperin RS.Fibrotic atrial cardiomyopathy, atrial fibrillation and thromboembolism: mechanistic links and clinical inferences[J].J Am Coll Cardiol, 2015,65(2):2239-2251.
[12] Matsue Y,Suzuki M,Abe M,et al.Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state.Comparison with permanent/persistent atrial fibrillation[J].J Atheroscler Thromb,2011,18(4):298-304.
[13] Wong CX,Lim HS,Schultz CD,et al.Assessment of endothelial function in atrial fibrillation:utility of peripheral arterial tonometry[J].Clin Exp Pharmacol Physiol, 2012,39(2):141-144.
[14] Katoh S,Honda S,Watanabe T,et al.Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis[J].Heart Vessels,2014,29(2):263-272.
[15] Ko D,Magnani JW,Hylek EM.Biomarkers in lone atrial fibrillation—an additional ‘fine tuning' of risk[J].Curr Pharm Des,2015,21(5):645-658.
[16] Krishnamoorth S,Khoo CW,Lim HS,et al.Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a ‘real-world' community cohort of patients with atrial fibrillation[J].Eur J Clin Invest,2013,43(10):1032-1038.
[17] Goette A,Hammwohner M,Bukowska A,et al.The impact of rapid atrial pacing on ADMA and endothelial NOS[J].Int J Cardiol,2012,154(2):141-146.
[18] Chao TF,Lu TM,Lin YJ,et al.Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram[J].PLoS One,2013,8(8):e71675.
[19] Dharmasaroja P,Dharmasaroja PA,Sobhon P.Increased plasma soluble thrombomodulin levels in cardioembolic stroke[J].Clin Appl Thromb Hemost,2012,18(3):289-293.
[20] Jorge C,Ramon M,Francisco E,et al.Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype.A role in cardioembolic stroke[J].Stroke,2011,42(9):2622-2624.
[21] Kottkamp H.Fibrotic atrial cardiomyopathy:a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease[J].J Cardiovasc Electrophysiol,2012,23(7):797-799.
[22] Marrouche NF,Wilber D,Hindricks G.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation[J].JAMA,2014,311(5):498-506.
[23] Wu N,Chen X,Cai T,et al.Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis[J].Can J Cardiol,2015,31(3):278-286.
[24] Berge T,Ulimoen SR,Enger S,et al.Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly[J].Scand J Clin Lab Invest,20113,73(4): 326-333.
[25] Rubanenko AO,Shchukinlu V. Factors associated with thrombosis of the left atrial appendage in patients with chronic atrial fibrillation[J]. Klin Med(Mosk), 2014,92(11):29-34.
[26] Zbczyk M,Majewski J,Lelakowski J.Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation[J].Pol Arch Med Wewn,2011,121(11):400-407.
[27] Choudhury A,Chung I,Blann AD,et al.Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy[J].Chest,2007,131(3):809-815.
[28] Guo Y,Lip GY,Apostolakis S.Inflammation in atrial fibrillation[J].J Am Coll Cardiol,2012,60(22):2263-2270.
[29] Yashiro Y,Arimoto T,Hashimoto N,et al.Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients[J].Circ J,2015,79(1):61-69.
[30] Jesel L,Arentz T,Herrera-Siklody C,et al.Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation[J].J Cardiovasc Electrophysiol,2014,25(3):266-270.
[31] Breitenstein A,Glanzmann M,Falk V,et al.Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients[J].Int J Cardiol,2015, 185(2015):250-255.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(6):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(6):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(6):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(6):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(6):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]